Latest Biotech News

Teva Pharmaceuticals has secured FDA approval for the first generic glucagon-like peptide-1 (GLP-1) injectable therapy for weight loss, expanding treatment options amid high demand. The drug, a...

Royalty Pharma has acquired rights to Amgen’s Imdelltra (tarlatamab-dlle), an FDA-accelerated approval immunotherapy for extensive-stage small cell lung cancer (ES-SCLC), in a deal valued up to...

Researchers at Mount Sinai have developed a Graph Neural Network (GNN)-based artificial intelligence model to better identify atrial fibrillation patients who need anticoagulation therapy to...

A transformative advance in genome editing technology reports that wrapping CRISPR components in DNA-coated nanoparticles significantly enhances editing efficiency, tripling successful gene...

Researchers have introduced SC134-deruxtecan, a new antibody-drug conjugate designed to selectively target fucosyl-GM1 in small cell lung cancer (SCLC), a notoriously aggressive malignancy with...

A recent study highlights microRNA miR-125a-5p as a key inhibitor of hepatic stellate cell activation by modulating the TGF-β/Smad2/3 signaling pathway, attenuating liver fibrosis progression....

Recent studies provide real-world evidence supporting the benefits of polyethylene glycol loxenatide combined with basal insulin for type 2 diabetes management, as well as oral semaglutide's role...

Leveraging artificial intelligence, researchers have mined venom peptides from snakes, spiders, and scorpions to identify novel antimicrobial compounds demonstrating potent activity against...

Groundbreaking research has identified fecal microRNA miR-92a as a sensitive, non-invasive biomarker for advanced colorectal neoplasia screening. This innovation offers an accessible alternative...

As Blood Cancer Awareness Month commences, industry insights reveal promising biotechnological advancements across hematological malignancies. Pipeline developments include novel immunotherapies,...

Royalty Pharma has acquired a royalty interest in Amgen's immunotherapy Imdelltra (tarlatamab-dlle), designed for extensive-stage small cell lung cancer (ES-SCLC), in a deal valued up to $950...

Researchers led by the University of Pennsylvania employed artificial intelligence to screen venom-derived peptides, discovering potent new antimicrobial compounds amid the pressing threat of...

An opinion piece emphasizes the necessity for the FDA to expedite regulatory pathways for therapies targeting rare diseases. The current pace of drug approvals is considered insufficient given the...

Mount Sinai researchers developed a Graph Neural Network-based AI that precisely identifies which patients with atrial fibrillation require anticoagulant therapy to prevent stroke. Leveraging...

UCLA engineers created a wearable, noninvasive brain-computer interface enhanced by artificial intelligence acting as a co-pilot to decode user intent. This system facilitates control of assistive...

Recent studies underscore the role of transcription factor Nrf2 and the emerging class of BH3 mimetics in overcoming chemoresistance in acute myeloid leukemia (AML). Nrf2 modulates cellular...

A study published in Nature Communications quantitatively links climate change-driven surface water scarcity to increased transboundary conflicts. The research reveals how hydrological stress due...

Innovative AI frameworks demonstrate enhanced accuracy in cancer diagnostics through medical imaging analysis. The OncoMet deep learning system predicts esophageal cancer progression by decoding...

The convergence of CRISPR technology and artificial intelligence is accelerating viral pathogen detection and genome editing precision. A novel CRISPR-based assay enables rapid identification of...

Royalty Pharma's $950 million acquisition of a royalty interest in Amgen’s approved small cell lung cancer drug, Imdelltra, underlines expanding market confidence. Imdelltra employs bispecific...